PubMed

Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease.

Tadiboyina VT, Liu DM, Miskie BA, Wang J, Hegele RA.

Lipids Health Dis. 2005 Oct 28;4:26.PMID: 16255772 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.

Pisciotta L, Fresa R, Bellocchio A, Pino E, Guido V, Cantafora A, Di Rocco M, Calandra S, Bertolini S.

Mol Genet Metab. 2009 Jun;97(2):143-8. Epub 2009 Feb 26.PMID: 19307143 [PubMed - indexed for MEDLINE]Related citations

Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease.

Rassoul F, Richter V, Lohse P, Naumann A, Purschwitz K, Keller E.

Int J Clin Pharmacol Ther. 2001 May;39(5):199-204.PMID: 11380065 [PubMed - indexed for MEDLINE]Related citations

Lovastatin therapy for cholesterol ester storage disease in two sisters.

Tarantino MD, McNamara DJ, Granstrom P, Ellefson RD, Unger EC, Udall JN Jr.

J Pediatr. 1991 Jan;118(1):131-5.PMID: 1986080 [PubMed - indexed for MEDLINE]Related citations

Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.

Rivers SM, Kane MP, Busch RS, Bakst G, Hamilton RA.

Endocr Pract. 2007 Jan-Feb;13(1):11-6.PMID: 17360295 [PubMed - indexed for MEDLINE]Related citations

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, Machida Y, Aoyama N, Masuda T, Izumi T.

Lipids Health Dis. 2009 Oct 12;8:41.PMID: 19821987 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.

Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.PMID: 16503317 [PubMed - indexed for MEDLINE]Related citations

Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study.

Sharma M, Sharma DR, Singh V, Panwar RB, Hira HS, Mohan B, Kumar N, Sharma SK, Gupta R.

Vasc Health Risk Manag. 2006;2(1):87-93.PMID: 17319473 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin.

Gasche C, Aslanidis C, Kain R, Exner M, Helbich T, Dejaco C, Schmitz G, Ferenci P.

J Hepatol. 1997 Oct;27(4):744-50.PMID: 9365051 [PubMed - indexed for MEDLINE]Related citations

Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.

Strony J, Hoffman R, Hanson M, Veltri E.

Clin Ther. 2008 Dec;30(12):2280-97.PMID: 19167588 [PubMed - indexed for MEDLINE]Related citations

Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy.

Le VV, Racine N, Pelletier GB, Carrier M, Cossette M, White M.

Clin Transplant. 2009 Mar;23(2):249-55.PMID: 19402219 [PubMed - indexed for MEDLINE]Related citations

A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease.

Seedorf U, Wiebusch H, Muntoni S, Christensen NC, Skovby F, Nickel V, Roskos M, Funke H, Ose L, Assmann G.

Arterioscler Thromb Vasc Biol. 1995 Jun;15(6):773-8.PMID: 7773732 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.

González CA, Rubio-Guerra AF, Pavía A, Redding FJ, Cervantes JL, Zacarías JL, Yza R, Carranza J, Fernández P, Morales E, Robles FJ, Leyva JL, Rodríguez L.

Clin Drug Investig. 2007;27(5):333-7.PMID: 17451281 [PubMed - indexed for MEDLINE]Related citations

Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

Aslanidis C, Ries S, Fehringer P, Büchler C, Klima H, Schmitz G.

Genomics. 1996 Apr 1;33(1):85-93.PMID: 8617513 [PubMed - indexed for MEDLINE]Related citations

Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study.

Ansquer JC, Bekaert I, Guy M, Hanefeld M, Simon A; Study Investigators.

Am J Cardiovasc Drugs. 2009;9(2):91-101. doi: 10.2165/00129784-200909020-00003.PMID: 19331437 [PubMed - indexed for MEDLINE]Related citations

Safety and efficacy of treatment of pediatric cholesteryl ester storage disease with lovastatin.

Glueck CJ, Lichtenstein P, Tracy T, Speirs J.

Pediatr Res. 1992 Nov;32(5):559-65.PMID: 1480458 [PubMed - indexed for MEDLINE]Related citations

Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.

Lohse P, Maas S, Sewell AC, van Diggelen OP, Seidel D.

J Lipid Res. 1999 Feb;40(2):221-8.PMID: 9925650 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Effects of ezetimibe on lipids and lipoproteins in patients with hypercholesterolemia and different apolipoprotein E genotypes.

Mark L, Dani G, Fazekas O, Szüle O, Kovacs H, Katona A.

Curr Med Res Opin. 2007 Jul;23(7):1541-8.PMID: 17559752 [PubMed - indexed for MEDLINE]Related citations

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

Curr Med Res Opin. 2007 Aug;23(8):2009-26.PMID: 17659159 [PubMed - indexed for MEDLINE]Related citations

The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.

Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A.

Transplant Proc. 2008 Nov;40(9):3060-2.PMID: 19010194 [PubMed - indexed for MEDLINE]Related citations